LifeVantage (NASDAQ:LFVN) Earns Strong-Buy Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “strong-buy” rating on the stock.

LifeVantage Trading Down 10.4 %

LFVN opened at $4.06 on Thursday. The stock’s 50 day simple moving average is $3.65 and its 200-day simple moving average is $3.76. The stock has a market cap of $51.97 million, a PE ratio of -67.67 and a beta of 1.09. LifeVantage has a 1 year low of $3.04 and a 1 year high of $4.92.

Hedge Funds Weigh In On LifeVantage

Institutional investors and hedge funds have recently bought and sold shares of the business. Renaissance Technologies LLC increased its holdings in LifeVantage by 0.3% in the second quarter. Renaissance Technologies LLC now owns 974,318 shares of the company’s stock valued at $4,238,000 after purchasing an additional 3,300 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in LifeVantage by 4.6% in the first quarter. Dimensional Fund Advisors LP now owns 271,614 shares of the company’s stock valued at $1,293,000 after purchasing an additional 11,964 shares during the last quarter. BlackRock Inc. increased its holdings in LifeVantage by 10.5% in the first quarter. BlackRock Inc. now owns 249,547 shares of the company’s stock valued at $1,188,000 after purchasing an additional 23,788 shares during the last quarter. EP Wealth Advisors LLC bought a new stake in LifeVantage in the first quarter valued at about $234,000. Finally, State Street Corp increased its holdings in LifeVantage by 7.6% in the first quarter. State Street Corp now owns 46,191 shares of the company’s stock valued at $220,000 after purchasing an additional 3,281 shares during the last quarter. Institutional investors and hedge funds own 29.69% of the company’s stock.

About LifeVantage

(Get Rating)

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs.